HUP0003718A3 - Fused thiophene derivatives, use thereof and pharmaceutical compositions containing them - Google Patents

Fused thiophene derivatives, use thereof and pharmaceutical compositions containing them

Info

Publication number
HUP0003718A3
HUP0003718A3 HU0003718A HUP0003718A HUP0003718A3 HU P0003718 A3 HUP0003718 A3 HU P0003718A3 HU 0003718 A HU0003718 A HU 0003718A HU P0003718 A HUP0003718 A HU P0003718A HU P0003718 A3 HUP0003718 A3 HU P0003718A3
Authority
HU
Hungary
Prior art keywords
pharmaceutical compositions
compositions containing
thiophene derivatives
fused thiophene
fused
Prior art date
Application number
HU0003718A
Other languages
English (en)
Original Assignee
Welfide Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27322564&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0003718(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Welfide Corp filed Critical Welfide Corp
Publication of HUP0003718A2 publication Critical patent/HUP0003718A2/hu
Publication of HUP0003718A3 publication Critical patent/HUP0003718A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HU0003718A 1997-09-02 1998-08-31 Fused thiophene derivatives, use thereof and pharmaceutical compositions containing them HUP0003718A3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP23670097 1997-09-02
JP27777197 1997-10-09
JP16572598 1998-06-12
PCT/JP1998/003915 WO1999011647A1 (fr) 1997-09-02 1998-08-31 Composes thiophene condenses et leur utilisation en medecine

Publications (2)

Publication Number Publication Date
HUP0003718A2 HUP0003718A2 (hu) 2001-09-28
HUP0003718A3 true HUP0003718A3 (en) 2002-11-28

Family

ID=27322564

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0003718A HUP0003718A3 (en) 1997-09-02 1998-08-31 Fused thiophene derivatives, use thereof and pharmaceutical compositions containing them

Country Status (16)

Country Link
US (2) US6271225B1 (hu)
EP (1) EP1016664B1 (hu)
JP (2) JP3156933B2 (hu)
KR (1) KR20010021989A (hu)
CN (1) CN1268949A (hu)
AT (1) ATE244245T1 (hu)
AU (1) AU739385B2 (hu)
BR (1) BR9814042A (hu)
CA (1) CA2302409A1 (hu)
DE (1) DE69816102D1 (hu)
HU (1) HUP0003718A3 (hu)
IL (1) IL134812A0 (hu)
NO (1) NO20001049L (hu)
NZ (1) NZ503484A (hu)
RU (1) RU2197491C2 (hu)
WO (1) WO1999011647A1 (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
AU4354900A (en) 1999-04-16 2000-11-02 Kosan Biosciences, Inc. Ketolide antibacterials
US6608053B2 (en) * 2000-04-27 2003-08-19 Yamanouchi Pharmaceutical Co., Ltd. Fused heteroaryl derivatives
US6751036B2 (en) * 2000-08-04 2004-06-15 Seagate Technology Llc Tuning track density for data storage device
JP4544857B2 (ja) * 2001-06-11 2010-09-15 ヴァイロケム ファーマ インコーポレイテッド Ｆｌａｖｉｖｉｒｕｓ感染の治療または予防のための化合物および方法
US8329924B2 (en) * 2001-06-11 2012-12-11 Vertex Pharmaceuticals (Canada) Incorporated Compounds and methods for the treatment or prevention of Flavivirus infections
WO2004014895A1 (en) * 2002-08-05 2004-02-19 Eli Lilly And Company Piperazine substituted aryl benzodiazepines
US7402608B2 (en) * 2002-12-10 2008-07-22 Virochem Pharma Inc. Compounds and methods for the treatment or prevention of Flavivirus infections
US20040236181A1 (en) * 2003-04-01 2004-11-25 Olympus Corporation In-body information acquiring apparatus and power-supply circuit
WO2005026177A1 (en) * 2003-09-09 2005-03-24 Eli Lilly And Company Substituted piperazines of azepines, oxazepines, and thiazepines
EP1713486A4 (en) 2003-12-02 2009-04-29 Sheldon Leslie James COMBINED THERAPY FOR THE TREATMENT OF DEMENTIA, DEPRESSION AND APATHY
PT1611139E (pt) * 2003-12-22 2008-07-17 Teva Pharma Métodos de preparação de olanzapina
US7807828B2 (en) * 2005-08-11 2010-10-05 Hypnion, Inc. Olanzapine analogs and methods of use thereof
KR20090086081A (ko) * 2006-11-15 2009-08-10 바이로켐 파마 인코포레이티드 플라비바이러스 감염의 치료 또는 예방용 티오펜 유사체
PL395468A1 (pl) 2011-06-29 2013-01-07 Adamed Spólka Z Ograniczona Odpowiedzialnoscia Zwiazki amidoalkilopiperazynylowe do leczenia chorób osrodkowego ukladu nerwowego
JP6551671B2 (ja) * 2015-08-11 2019-07-31 国立大学法人 熊本大学 アルツハイマー治療薬
US20220242882A1 (en) * 2019-05-10 2022-08-04 Dana-Farber Cancer Institute, Inc. Small-molecule focal adhesion kinase (fak) inhibitors

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL140242B (nl) 1963-03-01 1973-11-15 Wander Ag Dr A Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen.
CH468400A (de) 1965-12-23 1969-02-15 Sandoz Ag Verfahren zur Herstellung neuer Thieno(2,3-b)(1,5)benzothiazepin-4-on-Verbindungen
US3683084A (en) 1969-02-06 1972-08-08 Jean Schmutz Basically substituted heterocycles as anti-emetics
US3726977A (en) 1969-02-06 1973-04-10 Sandoz Ag 2-NITRO-11-(1-PIPERAZINYL)-DIBENZ (b,f) (1,4) OXAZEPINES COMPOSITIONS IN THE TREATMENT OF DEPRESSION
US3962248A (en) * 1972-04-04 1976-06-08 Sandoz, Inc. Process for making 11-piperazino-diazepines, oxazepines, thiazepines and azepines
SU629879A3 (ru) * 1974-11-26 1978-10-25 Лилли Индастриз Лимитед, (Фирма) Способ получени тиено(1,5) бензодиазепинов или их солей
US4172831A (en) 1974-11-26 1979-10-30 Lilly Industries Limited Thieno-benzodiazepines
US4115568A (en) 1974-11-26 1978-09-19 Lilly Industries Limited Thieno[3,2-b]-[1,5]benzodiazepines
GB1533236A (en) * 1975-11-24 1978-11-22 Lilly Industries Ltd Thieno(1,5)benzodiazepine intermediates
US4157444A (en) 1978-03-13 1979-06-05 American Cyanamid Company 10-(Piperazinyl)thieno[3,4-b][1,5]benzoxazepines and 10-(piperazinyl)thieno[3,4-b][1,5]benzothiazepines
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
US5538965A (en) 1993-12-23 1996-07-23 Allelix Biopharmaceuticals Inc. Dopamine receptor ligands
US5602120A (en) 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. Benzyl-substituted compounds having dopamine receptor affinity
US5602124A (en) 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands
US5700445A (en) 1994-12-12 1997-12-23 Allelix Biopharmaceuticals, Inc. N-methyl piperazine compounds having dopamine receptor affinity
US5602121A (en) 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. Alkyl-substituted compounds having dopamine receptor affinity
US5576314A (en) 1994-12-12 1996-11-19 Allelix Biopharmaceuticals Inc. Bicyclic nonane and decane compounds having dopamine receptor affinity
US5561127A (en) 1994-12-19 1996-10-01 Allelix Biopharmaceuticals, Inc. Muscarinic receptor ligands

Also Published As

Publication number Publication date
DE69816102D1 (de) 2003-08-07
KR20010021989A (ko) 2001-03-15
JP3156933B2 (ja) 2001-04-16
EP1016664A1 (en) 2000-07-05
JP4354106B2 (ja) 2009-10-28
IL134812A0 (en) 2001-04-30
NO20001049D0 (no) 2000-03-01
AU8889098A (en) 1999-03-22
HUP0003718A2 (hu) 2001-09-28
EP1016664A4 (en) 2001-01-24
US6455521B1 (en) 2002-09-24
CA2302409A1 (en) 1999-03-11
US6271225B1 (en) 2001-08-07
BR9814042A (pt) 2000-10-03
NZ503484A (en) 2001-10-26
AU739385B2 (en) 2001-10-11
RU2197491C2 (ru) 2003-01-27
NO20001049L (no) 2000-04-03
ATE244245T1 (de) 2003-07-15
EP1016664B1 (en) 2003-07-02
WO1999011647A1 (fr) 1999-03-11
JP2001072684A (ja) 2001-03-21
CN1268949A (zh) 2000-10-04
US20020042411A1 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
HUP0003999A3 (en) Fused 1,2,4-thiadiazine derivatives, their preparation, their use and pharmaceutical compositions containing them
IL123648A0 (en) 1,4-Benzothiazepine-1,1-dioxides their preparation and pharmaceutical compositions containing them
HUP0001125A3 (en) Fused pyrimidine derivatives and their open chain analogues, pharmaceutical compositions thereof
HUP9902455A3 (en) 6-phenylpyridyl-2-amine derivatives, pharmaceutical compositions containing them
IL134961A0 (en) Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them
HUP0001508A3 (en) 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them
HUP0103884A3 (en) Arylsulfonanilide urea-derivatives, pharmaceutical compositions containing them and their use
HUP0400540A3 (en) 2-pyrazolin-5-one derivatives, their use and pharmaceutical compositions containing them
HUP0204081A3 (en) 4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use
SI0918059T1 (en) Substituted imidazoline derivatives, their preparation, their use, and pharmaceutical compositions containing them
HUP0002272A3 (en) Aroyl-piperazine derivatives, their preparation pharmaceutical compositions containing them and their use
HUP9904694A3 (en) Spiropyrrolidine derivatives, their use and pharmaceutical compositions containing them
HUP0004359A3 (en) Fused pyrazine derivatives and pharmaceutical compositions containing them
HUP9802937A3 (en) Benzo[g]quuinoline derivatives, pharmaceutical compositions containing them and their use
HUP0101381A3 (en) Benzofurylpyrone derivatives and pharmaceutical compositions containing them
HUP0203194A3 (en) Phenylpiperazines, pharmaceutical compositions containing them and their use
HUP0000762A3 (en) 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines, and pharmaceutical compositions containing them
HUP0203735A3 (en) 4-pyridinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use
HUP0003718A3 (en) Fused thiophene derivatives, use thereof and pharmaceutical compositions containing them
AU3053199A (en) Fused thiophene derivatives and drugs containing the same as the active ingredient
HUP9800147A3 (en) Isoxasol-and crotonoil-amide derivatives and pharmaceutical and diagnostical compositions containing them
HUP0105075A3 (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives, their use and pharmaceutical compositions containing them
HUP0004561A3 (en) Dihydrobenzofurans, pharmaceutical compositions containing them and use thereof
HUP9903280A3 (en) Thiophene derivatives and drug compositions containing the same
HUP9802132A3 (en) Biphenyl-sulfonyl-cyanamides, their use and pharmaceutical compositions containing them